{"id":"https://openalex.org/W2139170222","doi":"https://doi.org/10.1192/bjp.175.6.591a","title":"Venlafaxine and paroxetine in treatment-resistant depression","display_name":"Venlafaxine and paroxetine in treatment-resistant depression","alternate_titles":[],"publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W2139170222","doi":"https://doi.org/10.1192/bjp.175.6.591a","mag":"2139170222","pmid":"https://pubmed.ncbi.nlm.nih.gov/10789369"},"language":"en","primary_location":{"id":"doi:10.1192/bjp.175.6.591a","doi":"https://doi.org/10.1192/bjp.175.6.591a","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.175.6.591a","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D6C1B8AEE9B0BA8D3A43852171D0A89C/S0007125000263514a.pdf/div-class-title-venlafaxine-and-paroxetine-in-treatment-resistant-depression-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139170222"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D6C1B8AEE9B0BA8D3A43852171D0A89C/S0007125000263514a.pdf/div-class-title-venlafaxine-and-paroxetine-in-treatment-resistant-depression-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060213227","display_name":"Jillian R. Gregson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163178","display_name":"Alfred Health","ror":"https://ror.org/04scfb908","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210163178"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"J. Gregson","raw_affiliation_strings":["Alfred Child and Adolescent Mental Health Service, 594 St Kilda Road, Melbourne, Victoria 3004, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alfred Child and Adolescent Mental Health Service, 594 St Kilda Road, Melbourne, Victoria 3004, Australia","institution_ids":["https://openalex.org/I4210163178"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060213227"],"corresponding_institution_ids":["https://openalex.org/I4210163178"],"apc_list":{"value":4920,"currency":"USD","value_usd":4920},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":170,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"175","issue":"6","first_page":"591","last_page":"591"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.996999979019165},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6919999718666077},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8730000257492065},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.9599999785423279}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9382143616676331},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.9217848777770996},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6693312525749207},{"id":"https://openalex.org/C2780791683","wikidata":"https://www.wikidata.org/wiki/Q846785","display_name":"Action (physics)","level":2,"score":0.4961281716823578},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.44648459553718567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3664867877960205},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.32929104566574097},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.12881243228912354},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.05092814564704895},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1192/bjp.175.6.591a","doi":"https://doi.org/10.1192/bjp.175.6.591a","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.175.6.591a","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D6C1B8AEE9B0BA8D3A43852171D0A89C/S0007125000263514a.pdf/div-class-title-venlafaxine-and-paroxetine-in-treatment-resistant-depression-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:10789369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10789369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of psychiatry : the journal of mental science","raw_type":"Comment"}],"best_oa_location":{"id":"doi:10.1192/bjp.175.6.591a","doi":"https://doi.org/10.1192/bjp.175.6.591a","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.175.6.591a","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D6C1B8AEE9B0BA8D3A43852171D0A89C/S0007125000263514a.pdf/div-class-title-venlafaxine-and-paroxetine-in-treatment-resistant-depression-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139170222.pdf","grobid_xml":"https://content.openalex.org/works/W2139170222.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1634744991","https://openalex.org/W1796828557","https://openalex.org/W1932724843","https://openalex.org/W1987131180","https://openalex.org/W1988861786","https://openalex.org/W2027044241","https://openalex.org/W2035817582","https://openalex.org/W2054061970","https://openalex.org/W2056513437","https://openalex.org/W2067800689","https://openalex.org/W2070618004","https://openalex.org/W2083991574","https://openalex.org/W2085973009","https://openalex.org/W2114613490","https://openalex.org/W2152769424","https://openalex.org/W2155891669","https://openalex.org/W2396872116","https://openalex.org/W2418345448","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2035679019","https://openalex.org/W2168840108","https://openalex.org/W1979994311","https://openalex.org/W2386811898","https://openalex.org/W7097049145","https://openalex.org/W70578903","https://openalex.org/W2005661986","https://openalex.org/W2206475630","https://openalex.org/W4205378384","https://openalex.org/W2059737686"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139170222","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}
